Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (2205)	12/18/2000 1:47:40 PM
From: Biomaven	Read Replies (1) of 4974

Well here's an offsetting one - some $200m worth: CAMBRIDGE, Mass. -(Dow Jones)- Biogen Inc.'s (BGEN) board authorized the repurchase of up to four million of the company's estimated 148 million shares outstanding. In a press release Monday, the biopharmaceutical company said the reacquired shares will be placed in treasury and used for general corporate purposes, such as employee stock option and stock purchase plans. Biogen will purchase the shares from time-to-time during the next two years. Shares of Biogen recently traded at $54, up $2.50, or 4.9%, on Nasdaq-volume of 2 million shares. Average daily volume is 2.6 million shares. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next